Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Comparative effectiveness and safety between reduced dose dabigatran, reduced dose rivaroxaban and warfarin in elderly Atrial Fibrillation Patients over 85 years

Trial Profile

Comparative effectiveness and safety between reduced dose dabigatran, reduced dose rivaroxaban and warfarin in elderly Atrial Fibrillation Patients over 85 years

Status: Completed
Phase of Trial: Phase IV

Latest Information Update: 23 Jul 2018

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Dabigatran etexilate (Primary) ; Rivaroxaban (Primary) ; Warfarin (Primary)
  • Indications Embolism and thrombosis; Myocardial infarction; Stroke
  • Focus Adverse reactions; Therapeutic Use
  • Most Recent Events

    • 04 Jul 2018 Results (n=4722) published in the Journal of the American Geriatrics Society.
    • 28 Nov 2017 New trial record
    • 15 Nov 2017 Results presented at the 90th Annual Scientific Sessions of the American Heart Association
Subscriber content

You need to be a logged in subscriber to view this content.

If your organization has a subscription then there are several options available to help you access AdisInsight, even while working remotely.

  • IP authentication when working within your organization’s network.
  • with username/password or try via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days.
  • Contact us at AsktheExpert.AdisInsight@springer.com for assistance.

If your organization does not have a subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Buy a PDF version of the profile.
  • Request a free trial
Back to top